Image

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Join a study on Mavorixafor for chronic neutropenic disorders and infections.

Recruiting
12 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)
A Study on Mavorixafor for Chronic Neutropenia Participants This study tests a drug, mavorixafor, for people with chronic neutropenia, a condition where the body doesn't have enough white blood cells called neutrophils, leading to frequent infections. The study checks if mavorixafor helps increase neutrophils and reduces infections. Participants can continue their usual treatments like antibiotics or other medicines while in the study. Key Points:
  • The study involves ongoing monitoring and may require visits for blood tests.
  • Participants must have had at least two serious infections in the past year.
  • People with secondary neutropenia, like those from infections or other diseases, cannot join.
Participants need stable treatment for at least four weeks before joining and throughout the study. Those with certain health conditions or on specific medications may not qualify. The goal is to find if mavorixafor can make life better for those with this challenging condition.
Print
Study details
    Neutropenia

NCT06056297

X4 Pharmaceuticals

7 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.